000129103 001__ 129103
000129103 005__ 20240228143409.0
000129103 0247_ $$2doi$$a10.1093/carcin/bgw008
000129103 0247_ $$2pmid$$apmid:26785733
000129103 0247_ $$2ISSN$$a0143-3334
000129103 0247_ $$2ISSN$$a1460-2180
000129103 0247_ $$2altmetric$$aaltmetric:5020850
000129103 037__ $$aDKFZ-2017-05108
000129103 041__ $$aeng
000129103 082__ $$a610
000129103 1001_ $$0P:(DE-HGF)0$$aMadhavan, Dharanija$$b0$$eFirst author
000129103 245__ $$aCirculating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
000129103 260__ $$aOxford$$bOxford Univ. Press$$c2016
000129103 3367_ $$2DRIVER$$aarticle
000129103 3367_ $$2DataCite$$aOutput Types/Journal article
000129103 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1522155034_24184
000129103 3367_ $$2BibTeX$$aARTICLE
000129103 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000129103 3367_ $$00$$2EndNote$$aJournal Article
000129103 520__ $$aMetastasis is the principal cause of high morbidity and mortality among breast cancer (BC) patients. Identification of markers that can be routinely monitored to predict onset of metastasis in BC patients and prognosis of metastatic breast cancer (MBC) patients would increase their median survival. In this study, plasma miRNAs of 40 MBC patients were profiled by TaqMan low density arrays and miRNAs with prognostic capacity were identified. The candidates were validated initially in the samples of 237 MBC patients and subsequently in 335 samples from an independent study cohort of BC patients. Sixteen miRNAs were established to be significantly associated with overall survival, and were termed as prognostic miRNA panel template (PROMPT). These included miR-141, miR-144, miR-193b, miR-200a, miR-200b, miR-200c, miR-203, miR-210, miR-215, miR-365, miR-375, miR-429, miR-486-5p, miR-801, miR-1260 and miR-1274a. Additionally, 11 of these miRNAs were also associated with progression-free survival. Their prognostic significance was further confirmed in samples from a second study cohort of BC patients. In addition, miR-200a, miR-200b, miR-200c, miR-210, miR-215 and miR-486-5p were found to be significantly associated with onset of metastasis up to 2 years prior to clinical diagnosis in BC patients. We have thus identified panels of miRNAs, which include metastasis promoting miR-200 family and miR-203, as well as oncogenic and tumor-suppressive miRNAs, that can serve as prognostic markers for MBC, and early detection markers of metastasis in BC.
000129103 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000129103 588__ $$aDataset connected to CrossRef, PubMed,
000129103 650_7 $$2NLM Chemicals$$aBiomarkers, Tumor
000129103 650_7 $$2NLM Chemicals$$aMicroRNAs
000129103 7001_ $$0P:(DE-He78)1b77697b886efcf3fe95a8839064c1cb$$aPeng, Cike$$b1$$udkfz
000129103 7001_ $$aWallwiener, Markus$$b2
000129103 7001_ $$0P:(DE-HGF)0$$aZucknick, Manuela$$b3
000129103 7001_ $$aNees, Juliane$$b4
000129103 7001_ $$aSchott, Sarah$$b5
000129103 7001_ $$0P:(DE-He78)3c7f9136fb168ffb766316ea4ca1a58b$$aRudolph, Anja$$b6$$udkfz
000129103 7001_ $$aRiethdorf, Sabine$$b7
000129103 7001_ $$0P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2$$aTrumpp, Andreas$$b8$$udkfz
000129103 7001_ $$aPantel, Klaus$$b9
000129103 7001_ $$aSohn, Christof$$b10
000129103 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b11$$udkfz
000129103 7001_ $$aSchneeweiss, Andreas$$b12
000129103 7001_ $$0P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aBurwinkel, Barbara$$b13$$eLast author$$udkfz
000129103 773__ $$0PERI:(DE-600)1474206-8$$a10.1093/carcin/bgw008$$gVol. 37, no. 5, p. 461 - 470$$n5$$p461 - 470$$tCarcinogenesis$$v37$$x1460-2180$$y2016
000129103 909CO $$ooai:inrepo02.dkfz.de:129103$$pVDB
000129103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000129103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1b77697b886efcf3fe95a8839064c1cb$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000129103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000129103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3c7f9136fb168ffb766316ea4ca1a58b$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000129103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000129103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000129103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000129103 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000129103 9141_ $$y2016
000129103 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000129103 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000129103 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000129103 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000129103 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000129103 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCARCINOGENESIS : 2015
000129103 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000129103 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000129103 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000129103 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000129103 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000129103 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000129103 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000129103 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000129103 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000129103 9201_ $$0I:(DE-He78)C080-20160331$$kC080$$lMolekulare Epidemiologie$$x0
000129103 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebserkrankungen$$x1
000129103 9201_ $$0I:(DE-He78)A010-20160331$$kA010$$lStammzellen und Krebs$$x2
000129103 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x3
000129103 980__ $$ajournal
000129103 980__ $$aVDB
000129103 980__ $$aI:(DE-He78)C080-20160331
000129103 980__ $$aI:(DE-He78)C020-20160331
000129103 980__ $$aI:(DE-He78)A010-20160331
000129103 980__ $$aI:(DE-He78)C060-20160331
000129103 980__ $$aUNRESTRICTED